A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2009
11/26/2009	CA2724821A1 Polymer derivative of docetaxel, method of preparing the same and uses thereof
11/26/2009	CA2724818A1 New optically pure compounds for improved therapeutic efficiency
11/26/2009	CA2724782A1 An anti-cancer cytotoxic monoclonal antibody
11/26/2009	CA2724742A1 Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
11/26/2009	CA2724715A1 Heterocycles as protein kinase inhibitors
11/26/2009	CA2724550A1 Combination antitumor therapy
11/26/2009	CA2724408A1 Methods and compositions comprising novel cationic lipids
11/26/2009	CA2724357A1 Novel thiophenediamine derivative having urea structure
11/26/2009	CA2723594A1 {f-19}-labeled l-glutamic acid and l-glutamine derivative (iii), use thereof and method for obtaining them
11/26/2009	CA2723459A1 Novel [f-18]-labelled l-glutamic acid and l-glutamine derivatives (ii), their use and processes for their preparation
11/26/2009	CA2721710A1 Triazine compounds as pi3 kinase and mtor inhibitors
11/26/2009	CA2721692A1 Triazine compounds as p13 kinase and mtor inhibitors
11/26/2009	CA2718918A1 Methods for treating or preventing colorectal cancer
11/25/2009	EP2123752A2 Novel nucleic acid
11/25/2009	EP2123676A1 Diagnosis and treatment of cancer by using anti-prg-3 antibody
11/25/2009	EP2123672A1 Modulation of IL-2- and IL-15- mediated T cell responses
11/25/2009	EP2123664A1 Novel sugar-linked chlorin derivative and process for production thereof
11/25/2009	EP2123663A1 Method for production of sugar oxazoline derivative
11/25/2009	EP2123662A1 Trehalose compound, process for production of the compound, and immuno-stimulative agent comprising the compound
11/25/2009	EP2123649A1 3-pyrrolo-cyclohexylene-2-dihydro-indolinone derivatives and uses thereof
11/25/2009	EP2123620A1 {F-19}-labeled L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them
11/25/2009	EP2123619A1 New [F-18]-marked L-glutamic acids and L-glutamic acid derivatives (II), application thereof and method for their manufacture
11/25/2009	EP2123305A1 Linear self-eliminating oligomers
11/25/2009	EP2123288A1 C<sb>70</sb>-containing liposome, method for producing the same, and use of the same
11/25/2009	EP2123286A1 A nanoparticle of glucidamin for treating tumor and preparation method thereof
11/25/2009	EP2123285A1 Nucleosidic phosphoantigens for use in VGAMMA9DELTA2 T cell-mediated therapy
11/25/2009	EP2123283A1 The tetracyclic anthraquinones possessing anti-cancer effect
11/25/2009	EP2123272A1 Adam inhibitor
11/25/2009	EP2123266A1 Cancer therapeutic agent and anti-carcinogenic agent
11/25/2009	EP2123260A1 Liposome formulation and process for preparation thereof
11/25/2009	EP2121722A2 Photoreactive ru (ii) complexes anchored on oligonucleotides, method for obtaining them and use thereof
11/25/2009	EP2121719A2 2-5a derivatives and their use as anti-cancer, anti-viral and anti-parasitic agents
11/25/2009	EP2121715A1 Blocking the migration or metastasis of cancer cells by affecting adhesion proteins and the uses of new compounds thereof
11/25/2009	EP2121711A1 Carborane-phosphonium compounds and their use in boron neutron capture therapy and imaging
11/25/2009	EP2121700A1 Substituted tetrahydroquinolines
11/25/2009	EP2121681A1 Compounds and method for treatment of cancer
11/25/2009	EP2121650A1 Isoflavone derivatives and uses thereof
11/25/2009	EP2121640A1 Novel semicarbazide and carbonylhydrazide derivatives useful as potassium channel modulators
11/25/2009	EP2121637A1 Anthranilamide inhibitors of aurora kinase
11/25/2009	EP2121634A1 Pyrimidine-2,4-diamine derivatives and their use as jak2 kinase inhibitors
11/25/2009	EP2121626A1 Benzimidazole derivatives
11/25/2009	EP2121614A1 Amino nicotinic and isonicotinic acid derivatives as dhodh inhibitors
11/25/2009	EP2121590A2 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors
11/25/2009	EP2121576A1 Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
11/25/2009	EP2121039A1 Nanoparticle clusters and methods for forming same
11/25/2009	EP2120999A2 Activin-actriia antagonists and uses for promoting bone growth in cancer patients
11/25/2009	EP2120978A2 Herbal composition and process for its preparation
11/25/2009	EP2120958A2 Stat3 inhibitor having anti-cancer activity and associated methods
11/25/2009	EP2120948A1 Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives
11/25/2009	EP2120933A1 Isoquinolinopyrrolopyridinones active as kinase inhibitors
11/25/2009	EP2120932A1 Indazole derivatives as kinase inhibitors for the treatment of cancer
11/25/2009	EP2120929A1 Use of inhibitors of the degradation of p27, in particular argyrin and derivatives thereof, for the treatment of proliferative diseases
11/25/2009	EP2120921A2 Use of aminolevulinic acid and derivatives thereof
11/25/2009	EP2120913A2 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
11/25/2009	EP2120912A1 Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor
11/25/2009	EP2120909A2 Treatments of therapy-resistant diseases comprising drug combinations
11/25/2009	EP2120900A2 Combination of lbh589 with other therapeutic agents for treating cancer
11/25/2009	EP2120569A2 Spirochromanon derivatives
11/25/2009	EP2120567A1 Prodrugs of substituted 1,3-dioxanes and their uses
11/25/2009	EP1482932B1 N3 alkylated benzimidazole derivatives as mek inhibitors
11/25/2009	EP1242385B1 Cytokine, especially tnf-alpha, inhibitors
11/25/2009	EP1210108B1 Use of leptin together with an inhibitor of vegf and/or an inhibitor of angiogenesis for the inhibition of endothelial cell proliferation
11/25/2009	EP0954585B1 Human telomerase reverse transcriptase promoter
11/25/2009	CN101589061A Antibody molecules which bind IL-17A and IL-17F
11/25/2009	CN101589059A Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
11/25/2009	CN101589058A Cancer therapeutic agent comprising anti-HB-EGF antibody as active ingredient
11/25/2009	CN101589056A Depsipeptides and their therapeutic use
11/25/2009	CN101589047A Cathepsin proteases inhibitors
11/25/2009	CN101589045A Imidazopyrazines as protein kinase inhibitors
11/25/2009	CN101589029A 1,2,3-triazole derivatives as sigma receptor inhibitors
11/25/2009	CN101589026A Method of treatment of glioma brain tumour
11/25/2009	CN101589025A Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors
11/25/2009	CN101589024A Novel minor groove binders
11/25/2009	CN101588820A Alpha-lactalbumin composition
11/25/2009	CN101588812A Specific therapy and medicament using integrin ligands for treating cancer
11/25/2009	CN101588801A Combination of IAP inhibitors and FLT3 inhibitors
11/25/2009	CN101588800A A method of administering an antitumor compound
11/25/2009	CN101588798A PAI-1 binding modulators for the treatment of ocular disorders
11/25/2009	CN101586167A Diagnosis reagent for primary hepatocellular carcinoma, reagent kit and prevention and cure medicaments
11/25/2009	CN101586155A Method for diagnosing non-small cell lung cancers
11/25/2009	CN101586142A Research approach for element for forcing knubble microenvironment and application thereof
11/25/2009	CN101586114A CEA positive regulation IL-15 tumor immunity gene therapy plasmid vector and application thereof
11/25/2009	CN101585888A glucosan aliphatic acid graft manufacturing method and use
11/25/2009	CN101585882A Fusion protein for treating breast cancer and application thereof
11/25/2009	CN101585881A An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/25/2009	CN101585880A Variable regions on heavy and light chains of antihuman IL-13R alpha 2 monoclonal antibodies
11/25/2009	CN101585868A Method for extracting natural colorant glycoprotein of eucheuma
11/25/2009	CN101585863A Method for preparing yamogenin
11/25/2009	CN101585861A N-glycosyl naphthocarbazole compound and synthesis method and application thereof
11/25/2009	CN101585860A 4',5,6-trimethoxy scutellarin as well as preparation method and pharmaceutical composition thereof
11/25/2009	CN101585859A Novel scutellarin derivative as well as preparation method and pharmaceutical composition thereof
11/25/2009	CN101585841A Guaianolide sesquiterpene dimers, preparation method thereof and use thereof
11/25/2009	CN101585809A Novel compound with antibacterial and antitumor activities
11/25/2009	CN101585757A Method for preparing curcumin, demethoxycurcumin and bisdemethoxycurcumin
11/25/2009	CN101584868A Application of NPTX gene on preparation of antineoplastic medicaments
11/25/2009	CN101584862A Diagnosing tumorigenicity and determining resistance to anticancer therapy
11/25/2009	CN101584861A Methods for enhancing innate and adaptive immunity and antigen immunogenicity
11/25/2009	CN101584860A Recombinant human Claudin18.2 tumor vaccine and preparation method thereof
11/25/2009	CN101584829A Traditional Chinese medicine for curing ovarian cysts
11/25/2009	CN101584824A Traditional Chinese medicine for treating rectum cancer

1 ... 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 ... 2211